![](/img/cover-not-exists.png)
PARP Inhibitor Olaparib Use in a BRCA1-Positive Patient With Metastatic Triple-Negative Breast Cancer, Without the Initial Use of Platinum-Based Chemotherapy, Showing Significant Rapid Near Resolution of Large Liver Metastasis While Patient Experienced Gout-Like Symptoms
Matthews Hew, Trevanne, Zuberi, LaraVolume:
7
Journal:
Journal of Investigative Medicine High Impact Case Reports
DOI:
10.1177/2324709619864989
Date:
January, 2019
File:
PDF, 454 KB
2019